Slamon, D., Eiermann, W., Robea, N., et al. (2009) Phase III Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC->T) with Doxornbicin and Cyclophosphamide Followed by Doeetaxel and Trastuzumab (AC->TH) with Docetaxel, Carboplatin and Trastuzumab (TCH) in HER2 Neu-Positive Early Breast Cancer Patients: BCIRG 006 Study. Cancer Research, 69, 62.

曲妥珠单抗、帕妥珠单抗联合多西他赛对晚期三阳性乳腺癌一线治疗的临床疗效
Clinical Efficacy of Trastuzumab, Pertuzumab and Docetaxel as First-Line Treatment for Metastatic Triple-Positive Breast Cancer

曹 宇, 孙 萍   

临床医学进展Vol.12 No.8, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.1281125, August 23 2022

曲妥珠单抗靶向治疗HER2阳性乳腺癌的研究进展
Research Progress of Trastuzumab Targeted Therapy for HER2-Positive Breast Cancer

胥世霜   

临床医学进展Vol.13 No.7, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.1371686, July 27 2023

曲妥珠单抗所致乳腺癌患者心脏毒性的中西医结合治疗进展
Research Progress of the Treatment of Combined Traditional Chinese and Western Medicine on Cardiotoxicity of Breast Cancer Patients Caused by Trastuzumab

项莲莲, 郝 炜   

中医学Vol.10 No.4, 全文下载: PDF HTML XML DOI:10.12677/TCM.2021.104069, July 8 2021

诱导化疗联合洛铂同期放化疗治疗局部晚期头颈部鳞癌临床研究
Clinical Studies on Induction Chemotherapy Followed by Concurrent Lobaplatin Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

陈 宇, 吴伟莉, 金 风, 李媛媛, 龙金华, 龚修云, 陈潇潇, 黄诗颖, 李卓玲, 毛振华, 周 亚   

世界肿瘤研究Vol.5 No.1, 全文下载: PDF HTML XML DOI:10.12677/WJCR.2015.51001, January 5 2015

L-精氨酸联合多西紫杉醇抗肺癌的研究
L-Arginine Combined with Docetaxel Inhibiting Lung Cancer

吴 斌, 魏 亮, 冯冰玉, 张 东, 祖元刚, 姜守刚   

临床医学进展Vol.10 No.5, 全文下载: PDF HTML XML DOI:10.12677/ACM.2020.105115, May 13 2020

DS-8201a治疗HER2表达实体肿瘤的研究进展
Research Progress of DS-8201a in the Treat-ment of HER2-Expressing Solid Tumors

王 宁, 岳 麓   

临床医学进展Vol.13 No.5, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.1351063, May 15 2023